首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of pharmacology and experimental therapeutics

缩写:J PHARMACOL EXP THER

ISSN:0022-3565

e-ISSN:1521-0103

IF/分区:4.3/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引5146条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Xinyu Zhao,Sydney R Cassel,Sarah E Eaton et al. Xinyu Zhao et al.
DNA topoisomerase IIα (TOP2α; 170 kDa, TOP2α/170) is a nuclear enzyme that plays a key role in chromosomal segregation at mitosis by catalyzing transient DNA double-stranded breaks, allowing replicated DNA duplexes to separate. Given its...
Archana Mishra,Biswa Ranjan Mishra,Rituparna Maiti et al. Archana Mishra et al.
Clozapine remains the only drug with superior efficacy in treatment-resistant schizophrenia (TRS) but is limited by underutilization and significant adverse effects, motivating mechanistic approaches to identify clozapine-like alternatives....
Emily M Jutkiewicz,Benjamin A Palleiko,Isaac J Dripps et al. Emily M Jutkiewicz et al.
The delta opioid receptor (DOR) has been a focus of research for the treatment of depression and certain pain disorders. Unfortunately, clinical translation of delta opioid agonists to humans has proved challenging partly because of their p...
Di Lu,Yang Zhou,Han Zhang et al. Di Lu et al.
Colorectal cancer (CRC) is a highly prevalent malignancy with a poor prognosis, and metabolic reprogramming (eg, glutamic acid metabolism) drives its progression. However, the key regulators of glutamic acid homeostasis in CRC remain undefi...
Yuexin Zhang,Xiaopei Hu,Jie Li et al. Yuexin Zhang et al.
Recent studies have revealed that exosomes, important regulators of intercellular communication, participate in various cardiac abnormalities, including hypertrophy. Cardiac fibroblasts (CFs) are one of the most abundant cell types of the h...
Rao N V S Mamidi,Mark Peakman,Wolfgang Schmider et al. Rao N V S Mamidi et al.
Teplizumab is a nonmitogenic anti-CD3 monoclonal antibody approved to delay the onset of clinical type 1 diabetes. To address the challenge of the absence of crossreactivity of teplizumab with CD3 of different preclinical species that are t...
Anna Zhang,Guoling Yang,Guojun Chu et al. Anna Zhang et al.
Heart failure (HF) poses a substantial challenge to healthcare systems globally, particularly at the advanced stages of various cardiac diseases, due to its high morbidity and mortality rates. This study aimed to assess the therapeutic pote...
Michele Marchetta,Rocio I Lopez,Nicola Potere et al. Michele Marchetta et al.
Low-density lipoprotein receptor-related protein-1 (LRP1) is a ubiquitously expressed, multifunctional membrane receptor that combines scavenger and signaling functions regulating, among others, lipid metabolism, inflammation and fibrosis p...
Ethan S Burstein,Roger Olsson,Niklas Skold et al. Ethan S Burstein et al.
Pimavanserin was the first US Food and Drug Administration approved antipsychotic drug that does not block D2 dopamine receptors at therapeutic doses. Pimavanserin is a selective 5-HT2A receptor inverse agonist that reduces the frequency of...